gemcitabine has been researched along with Thymoma in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| An, T; Chen, H; Dong, Z; Jia, B; Li, J; Shi, A; Wang, Y; Wang, Z; Wu, M; Yang, S; Yang, X; Zhao, J; Zhong, J; Zhuo, M | 1 |
| Chen, X; Dai, L; Fang, J; Han, J; Han, S; Hu, W; Long, J; Ma, X; Nie, J; Tian, G; Wang, Y; Zhang, Z | 1 |
| Hishima, T; Hosomi, Y; Okamura, T; Okuma, Y; Takahashi, S; Watanabe, K | 1 |
| Giaccone, G; Rajan, A | 1 |
| Abiko, M; Satoh, T | 1 |
1 review(s) available for gemcitabine and Thymoma
| Article | Year |
|---|---|
Chemotherapy for thymic tumors: induction, consolidation, palliation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Deoxycytidine; Doxorubicin; Fluorouracil; Gemcitabine; Humans; Methotrexate; Neoadjuvant Therapy; Palliative Care; Procarbazine; Thymoma; Thymus Neoplasms; Vincristine | 2011 |
4 other study(ies) available for gemcitabine and Thymoma
| Article | Year |
|---|---|
Optimal first-line treatment for advanced thymic carcinoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy, Adjuvant; Combined Modality Therapy; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Paclitaxel; Retrospective Studies; Survival Analysis; Thymoma; Thymus Neoplasms; Treatment Outcome; Young Adult | 2019 |
Efficacy and toxicities of gemcitabine and cisplatin combined with endostar in advanced thymoma and thymic carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Disease-Free Survival; Drug-Related Side Effects and Adverse Reactions; Endostatins; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Recombinant Proteins; Thymoma; Thymus Neoplasms; Uganda | 2019 |
Gemcitabine in patients previously treated with platinum-containing chemotherapy for refractory thymic carcinoma: radiographic assessment using the RECIST criteria and the ITMIG recommendations.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Male; Middle Aged; Platinum Compounds; Response Evaluation Criteria in Solid Tumors; Retreatment; Retrospective Studies; Thymoma; Thymus Neoplasms; Treatment Outcome | 2016 |
[Effect of preoperative concurrent chemo-radiotherapy for thymic carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Deoxycytidine; Drug Administration Schedule; Etoposide; Gemcitabine; Humans; Male; Middle Aged; Preoperative Care; Radiotherapy Dosage; Remission Induction; Thymoma; Thymus Neoplasms | 2002 |